NCT06606301View on ClinicalTrials.gov

Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

August 26, 2023

Primary Completion Date

November 30, 2023

Study Completion Date

December 28, 2023

Conditions
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Interventions
DIAGNOSTIC_TEST

BioSB EGFR antibody

Appropriate sections from the tumor will be selected basing the choice on tumor content and viability eventually followed by EGFR application which will reveal a brown membrane positivity for the tumor. Total score for RGFR will be calculated by the histopathologists.

Trial Locations (1)

46000

Armed Forces Institute of Pathology, Combined Military Hospital, Rawalpindi

All Listed Sponsors
collaborator

National University of Medical Sciences, Pakistan

OTHER

lead

Combined Military Hospital, Pakistan

OTHER